1. Home
  2. VYNE vs MIND Comparison

VYNE vs MIND Comparison

Compare VYNE & MIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYNE
  • MIND
  • Stock Information
  • Founded
  • VYNE 2003
  • MIND 1987
  • Country
  • VYNE United States
  • MIND United States
  • Employees
  • VYNE N/A
  • MIND N/A
  • Industry
  • VYNE Biotechnology: Pharmaceutical Preparations
  • MIND Industrial Machinery/Components
  • Sector
  • VYNE Health Care
  • MIND Industrials
  • Exchange
  • VYNE Nasdaq
  • MIND Nasdaq
  • Market Cap
  • VYNE 35.7M
  • MIND 40.6M
  • IPO Year
  • VYNE 2018
  • MIND 1994
  • Fundamental
  • Price
  • VYNE $1.31
  • MIND $6.67
  • Analyst Decision
  • VYNE Strong Buy
  • MIND
  • Analyst Count
  • VYNE 2
  • MIND 0
  • Target Price
  • VYNE $6.25
  • MIND N/A
  • AVG Volume (30 Days)
  • VYNE 223.6K
  • MIND 209.1K
  • Earning Date
  • VYNE 05-08-2025
  • MIND 06-09-2025
  • Dividend Yield
  • VYNE N/A
  • MIND N/A
  • EPS Growth
  • VYNE N/A
  • MIND N/A
  • EPS
  • VYNE N/A
  • MIND 4.32
  • Revenue
  • VYNE $605,000.00
  • MIND $46,863,000.00
  • Revenue This Year
  • VYNE N/A
  • MIND $5.56
  • Revenue Next Year
  • VYNE N/A
  • MIND N/A
  • P/E Ratio
  • VYNE N/A
  • MIND $1.56
  • Revenue Growth
  • VYNE 18.16
  • MIND 28.36
  • 52 Week Low
  • VYNE $1.27
  • MIND $3.05
  • 52 Week High
  • VYNE $4.30
  • MIND $11.10
  • Technical
  • Relative Strength Index (RSI)
  • VYNE 33.79
  • MIND 56.53
  • Support Level
  • VYNE $1.27
  • MIND $6.50
  • Resistance Level
  • VYNE $1.41
  • MIND $6.98
  • Average True Range (ATR)
  • VYNE 0.11
  • MIND 0.41
  • MACD
  • VYNE -0.02
  • MIND 0.10
  • Stochastic Oscillator
  • VYNE 0.00
  • MIND 66.24

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

About MIND MIND Technology Inc. (DE)

MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The Company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; Europe, Russia & CIS; Middle East & Africa; Asia-Pacific; and Canada & Latin America.

Share on Social Networks: